Sebolt JS - Search Results

1

Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro.

Sebolt JS, Scavone SV, Pinter CD, Hamelehle KL, Von Hoff DD, Jackson RC. Sebolt JS, et al. Cancer Res. 1987 Aug 15;47(16):4299-304. Cancer Res. 1987. PMID: 2440564

2

Activity of the pyrazoloacridines against multidrug-resistant tumor cells.

Sebolt J, Havlick M, Hamelehle K, Nelson J, Leopold W, Jackson R. Sebolt J, et al. Cancer Chemother Pharmacol. 1989;24(4):219-24. doi: 10.1007/BF00257621. Cancer Chemother Pharmacol. 1989. PMID: 2752501

3

The pyrazoloacridines: approaches to the development of a carcinoma-selective cytotoxic agent.

Jackson RC, Sebolt JS, Shillis JL, Leopold WR. Jackson RC, et al. Among authors: sebolt js. Cancer Invest. 1990;8(1):39-47. doi: 10.3109/07357909009017545. Cancer Invest. 1990. PMID: 2190673 Review. No abstract available.

4

In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721).

Roberts BJ, Hamelehle KL, Sebolt JS, Leopold WR. Roberts BJ, et al. Among authors: sebolt js. Cancer Chemother Pharmacol. 1986;16(2):95-101. doi: 10.1007/BF00256156. Cancer Chemother Pharmacol. 1986. PMID: 3081269

5

Enzymology of pyrimidine and carbohydrate metabolism in human colon carcinomas.

Denton JE, Lui MS, Aoki T, Sebolt J, Takeda E, Eble JN, Glover JL, Weber G. Denton JE, et al. Cancer Res. 1982 Mar;42(3):1176-83. Cancer Res. 1982. PMID: 7059974 No abstract available.

6

Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma.

Sebolt JS, Aoki T, Eble JN, Glover JL, Weber G. Sebolt JS, et al. Biochem Pharmacol. 1985 Jan 1;34(1):97-100. doi: 10.1016/0006-2952(85)90106-6. Biochem Pharmacol. 1985. PMID: 3966920

7

Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.

Denton JE, Lui MS, Aoki T, Sebolt J, Weber G. Denton JE, et al. Life Sci. 1982 Mar 29;30(13):1073-80. doi: 10.1016/0024-3205(82)90527-6. Life Sci. 1982. PMID: 7078346

8

In vivo inactivation by acivicin of carbamoyl-phosphate synthetase II in rat hepatoma.

Aoki T, Sebolt J, Weber G. Aoki T, et al. Biochem Pharmacol. 1982 Mar 15;31(6):927-32. doi: 10.1016/0006-2952(82)90322-7. Biochem Pharmacol. 1982. PMID: 7082374

9

Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.

Weber G, Prajda N, Lui MS, Denton JE, Aoki T, Sebolt J, Zhen YS, Burt ME, Faderan MA, Reardon MA. Weber G, et al. Adv Enzyme Regul. 1982;20:75-96. doi: 10.1016/0065-2571(82)90009-7. Adv Enzyme Regul. 1982. PMID: 6180609

10

Negative correlation of L-glutamine concentration with proliferation rate in rat hepatomas.

Sebolt JS, Weber G. Sebolt JS, et al. Life Sci. 1984 Jan 16;34(3):301-6. doi: 10.1016/0024-3205(84)90603-9. Life Sci. 1984. PMID: 6141511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters